Eikon Therapeutics Inc
NASDAQ:EIKN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Eikon Therapeutics Inc
NASDAQ:EIKN
|
US |
|
C
|
Cantor Equity Partners V Inc
NASDAQ:CEPV
|
US |
|
Euromax Resources Ltd
TSX:EOX
|
UK |
|
Australian Finance Group Ltd
ASX:AFG
|
AU |
|
VDM Group Ltd
ASX:VMG
|
AU |
|
FieldPoint Petroleum Corp
OTC:FPPP
|
US |
|
E
|
Empro Group Inc
NASDAQ:EMPG
|
MY |
Eikon Therapeutics Inc
Eikon Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Hayward, California. The company went IPO on 2026-02-05. Eikon Therapeutics, Inc. is a United States-based drug discovery and development company. The Company’s platform allows resolution microscopy as well as the advances in biology, chemistry, engineering, and automation. The company tracks and measures the real-time movement of individual proteins in living cells to understanding of disease biology and discover differentiated therapeutics.
Eikon Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Hayward, California. The company went IPO on 2026-02-05. Eikon Therapeutics, Inc. is a United States-based drug discovery and development company. The Company’s platform allows resolution microscopy as well as the advances in biology, chemistry, engineering, and automation. The company tracks and measures the real-time movement of individual proteins in living cells to understanding of disease biology and discover differentiated therapeutics.